Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice

Nadir Yalcin; Karel Allegaert

doi:10.1016/j.ymgme.2022.09.003

Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice

Nadir Yalcin
, Karel Allegaert^*

^*Corresponding author for this work

Pharmacy

Hacettepe University
KU Leuven

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

1 Downloads (Pure)

Original language	English
Pages (from-to)	210-212
Number of pages	3
Journal	Molecular Genetics and Metabolism
Volume	137
Issue number	1-2
DOIs	https://doi.org/10.1016/j.ymgme.2022.09.003
Publication status	Published - 1 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ymgme.2022.09.003

Fetal pharmacogenetic screening to improve neonatal pharmacotherapy, From feasibility to personalized practiceFinal published version, 231 KBLicence: Article 25fa Dutch Copyright Act

Cite this

@article{ba0956e2ae994a91b680d061a7ce9086,

title = "Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice",

author = "Nadir Yalcin and Karel Allegaert",

year = "2022",

month = sep,

day = "1",

doi = "10.1016/j.ymgme.2022.09.003",

language = "English",

volume = "137",

pages = "210--212",

journal = "Molecular Genetics and Metabolism",

issn = "1096-7192",

publisher = "Academic Press",

number = "1-2",

}

TY - JOUR

T1 - Fetal pharmacogenetic screening to improve neonatal pharmacotherapy

T2 - From feasibility to personalized practice

AU - Yalcin, Nadir

AU - Allegaert, Karel

PY - 2022/9/1

Y1 - 2022/9/1

UR - https://www.scopus.com/pages/publications/85138166957

U2 - 10.1016/j.ymgme.2022.09.003

DO - 10.1016/j.ymgme.2022.09.003

M3 - Comment/Letter to the editor

C2 - 36152474

AN - SCOPUS:85138166957

SN - 1096-7192

VL - 137

SP - 210

EP - 212

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

IS - 1-2

ER -

Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice

UN SDGs

Access to Document

Other files and links

Cite this